Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dragonfly Therapeutics
GI Innovation, Inc.
Compass Therapeutics
Mayo Clinic
Mayo Clinic
Hoffmann-La Roche
Neonc Technologies, Inc.
ViroMissile, Inc.
Arcus Biosciences, Inc.
Bristol-Myers Squibb
AstraZeneca
Pfizer
Duke University
Tizona Therapeutics, Inc
Genentech, Inc.
A2 Biotherapeutics Inc.
Poseida Therapeutics, Inc.
MacroGenics
National Institutes of Health Clinical Center (CC)
ImmunityBio, Inc.
M.D. Anderson Cancer Center
Ocellaris Pharma, Inc.
Novartis
Elephas
City of Hope Medical Center
Mayo Clinic